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Tuesday, March 3, 2009 515aand is detrimental to myocardial function. We previously demonstrated that
high levels of peroxynitrite decrease myocardial contraction by reducing phos-
pholamban (PLB) phosphorylation through a protein phosphatase-dependent
mechanism. However, we did not examine the direct effect of peroxynitrite
on protein phosphatase activity in the myocardium or the specific protein phos-
phatase which is activated. Here we test: 1.) the effect of SIN-1 (peroxynitrite
donor) on protein phosphatase activity in whole heart homogenates using a
colorimetric assay, and 2.) the effect of SIN-1 on the interaction of PLB with
protein phosphatase 1 (PP1) and protein phosphatase 2a (PP2a) using co-immu-
noprecipitation. SIN-1 induced a 63% increase in total protein phosphatase ac-
tivity (1.650.2 vs. 2.650.3 nmol/min/mg, p<0.05 vs. Control), which was
abolished with specific PP1/PP2a inhibition using okadaic acid (1.450.2
nmol/min/mg, p<0.05 vs. SIN-1). Since okadaic acid prevented the effects
of SIN-1, we next examined the effect of SIN-1 on the interaction of PLB
with PP1 and PP2a. SIN-1 increased the interaction of PLB with PP2a by
350% (0.65 0.3 vs. 2.750.7 A.U., p<0.05 vs. Control), but had no effect
on the interaction with PP1. The peroxynitrite scavenger, urate, prevented
both the SIN-1-induced increase in protein phosphatase activity and the inter-
action of PLB with PP2a, thus implicating peroxynitrite as the causal species.
The results of this study provide further insight into the mechanism through
which high levels of peroxynitrite serve to decrease PLB phosphorylation
and myocardial contraction. Therefore, increased peroxynitrite production
may play a key role in heart failure where protein phosphatase activity is in-
creased and PLB phosphorylation is decreased, ultimately leading to contractile
dysfunction.
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Epac is a protein directly activated by cAMP whose actions are independent of
PKA.We recently show that Epac induces activation of CaMKII and phosphor-
ylation of the Ca2þ release channel, the RyR, in rat cardiac myocytes. The
effects included an increase in the Ca2þ sparks frequency and a slight decrease
in the [Ca2þ]i transient amplitude. Here we investigated the signaling cascade
from Epac activation to its effects on Ca2þ release. Ventricular myocytes were
enzymatically isolated from rat heart ventricles. Cells were loaded with the
fluorescence Ca2þ indicator Fluo-3 AM and viewed by confocal miscroscopy.
[Ca2þ]i transients were evoked by field stimulation at 1 Hz. Ca
2þ sparks were
recorded in quiescent cells and SR Ca2þ load was estimated by rapid caffeine
exposure. Epac activation was analyzed in presence of 8-CPT and of various
antagonists. The possible involvement of Rap was checked on cells infected
with adenoviruses coding for Rap-GAP and GFP. The results show that Rap
is not involved in Epac effect on cardiomyocyte Ca2þ release. Inhibition of
PLC by U73122 completely prevented Epac actions on Ca2þ sparks and
[Ca2þ]i transients, indicating that PLC is involved in Epac actions. Blocking
PKC by chelerytrine completely prevented Epac effect on [Ca2þ]i transient
but not on Ca2þ sparks, suggesting that there are two separates pathways.
Because PLC activation produces IP3, we checked whether activation of IP3
receptors (IP3R) is involved in Epac actions. Blockade of IP3R by 2-APB
attenuated the effects of Epac on Ca2þ release events. Thus we conclude
that activation of Epac by cAMP leads to Ca2þ release events modulation
via a cascade involving PLC, PKC and IP3R. The resulted increase in the local
Ca2þ release might be involved in the prohypertrophic actions of Epac on
cardiac myocytes.
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Decreased SERCA2a activity has been associated with contractile dysfunction
in animal models of heart failure. An isolated working rabbit heart preparation
and direct SERCA activity measurements were used to assess the level of
SERCA inhibition necessary to terminate cardiac output under a standardised
set of haemodynamic conditions. Hearts were perfused with a physiological ex-
tracellular solution whilst preload and afterload were set at 10cmH2O and
85cmH2O repectively. Ventricular function was assessed through the use of
a pressure-volume catheter. Following initial stabilisation of cardiac function,
2.8mM thapsigargin (TG) was added to the circulating solution. Functional
parameters were assessed continuously before and during application of TG.
Cardiac function steadily declined in the presence of TG until the working heart
configuration could not be sustained. The time to termination of aortic flowranged from 15 to 60min. In the last minute prior to failure haemodynamic
characteristics were markedly impaired (steady state vs. TG, n¼4, p<0.05).
Peak systolic pressure (107.7853.66 vs. 82.4052.15mmHg) and the maxi-
mum rate of rise of pressure (dp/dtmax) (19515177 vs. 995522mmHg.s
-1)
were significantly reduced whilst dp/dtmin (-24225178 vs. -14705
122mmHg.s-1), relaxation time constant (0.02850.004 vs. 0.06650.009ms)
and end diastolic pressure (8.3351.85 vs. 11.6550.62mmHg) were signifi-
cantly increased. In all hearts coronary flow was maintained (80.551.26 vs.
79.5051.7ml.min-1). On cessation of aortic flow the left ventricle was snap
frozen and homogenised in a protease-phosphatase buffer solution before
biochemical analysis. Oxalate-dependent SERCA-mediated Ca2þ-uptake was
used to assess SR Ca2þ uptake at a range of homogenate protein concentrations.
Initial measurements indicate that termination of aortic flow occurs when
SERCA activity (Vmax) is reduced to <15% of control (DMSO vehicle). These
data indicate the minimum level of SERCA activity required to sustain cardiac
output in the rabbit working heart preparation.
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Modulation of contractile force via changes in heart rate can occur through pro-
cesses that are either immediate (intrinsic) and/or through processes that in-
volve prolonged exposure to a given situation and act via post-translational
modification. Because the contractile strength of the steady state force-fre-
quency relationship (FFR) and post-rest potentiation (PRP) involve both instant
intrinsic responses to cycle length as well as slower acting components such as
post-translational modification based mechanisms, it remains unclear how
cycle length intrinsically affects cardiac contraction and relaxation. To dissect
the intrinsic impact of cycle length changes from slower acting signaling com-
ponents of the FFR, twitch contractions of right ventricular rabbit trabeculae at
5 different cycle lengths were randomized around a physiological stimulation
baseline of 2.85 Hz. Patterns of previous cycle lengths that resulted in changes
in force and/or relaxation times were identified. We found that the duration of
the cycle length prior to the analyzed twitch contraction (primary) positively
correlated with force. In sharp contrast, the cycle length one more removed
from the analyzed twitch (‘‘secondary’’) was found to have a negative correla-
tion with force. The ‘‘tertiary’’ cycle length impacted force similar to the
secondary cycle length, albeit with a lesser magnitude. Using this novel
stimulation protocol we can quantify the intrinsic effect of cycle length on con-
tractile strength, as well as avoiding run-down and lengthiness that are often
complications of FFR and PRP assessments. The data show that the history
of at least 3 cycle lengths prior to a contraction influences myocardial contrac-
tility under near physiological conditions, and the secondary/tertiary cycle
lengths affect cardiac twitch dynamics in the opposite direction than primary
cycle length with decreasing importance as the cycle length is further removed
from the current beat.
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HNO donors enhance cardiac inotropy by increasing SR Ca2þ re-uptake/re-
lease. Given its thiophylic nature, HNO likely modifyies critical cysteine resi-
dues in E-C coupling proteins. Phospholamban (PLN) is a potential target for
HNO, and its genetic removal or mutation of PLN cysteines should abolish/
blunt HNO cardiac effects. Cardiomyocytes were isolated from PLN knockout
(PLN-/-) and wildtype (WT) mice, field-stimulated and assessed for Ca2þ tran-
sients and sarcomere shortening (SS). HNO effects on the SR-Ca2þATPase
(SERCA2a) were evaluated by isolating SR vesicles from PLN-/- and WT
mice and measuring Ca2þ uptake by stopped-flow mixing. Dephosphorylation
of SERCA2a (a measure of E2P hydrolysis) was investigated in ER microsomes
from Sf21 insect cells expressing SERCA2a5PLN (WT or Cys 36-41-46-
>Ala mutant). PLN-/- myocytes showed enhanced myocyte contraction and
a blunted response to isoproterenol. When challenged with the HNO donor
